Dawn Alderman describes how AxioMx Inc. (http://www.axiomxinc.com/) uses PerkinElmer's Alpha no-wash assay technology at multiple stages of their antibody development pipeline, including primary detection, QC and KD determination. Dawn explains how the implementation of Alpha technology has eliminated throughput bottlenecks and simplified procedures.
https://youtu.be/UkN7aIb-GP4
